APRIL - 20235CXO INSIGHTSLAST WORD17PERSPECTIVES ON THE CURRENT LANDSCAPE OF TRANSCATHETER THERAPIES FOR AORTIC AND MITRAL VALVE DISEASEGilbert H. L. Tang, Surgical Director, Structural Heart Program,Mount Sinai Hospital and Aditya Sengupta,Cardiothoracic Surgery Resident, Mount Sinai Hospital2825COMPREHENSIVE, USER-CENTRIC DESIGN: THE FUTURE OF MEDICAL DEVICE INNOVATIONMarco Dolci, President of Cardiopulmonary, LivaNova [NASDAQ:LIVN]21REDUCING ADVERSE CARDIOVASCULAR AND RENAL OUTCOMES IN TYPE 2 DIABETES POPULATIONEduardo Haddad, Chief Medical Affairs, Lawrence General HospitalTHE USE OF VENOARTERIAL EXTRA-CORPOREAL MEMBRANE OXYGENATION FOR MECHANICAL CIRCULATORY SUPPORT OF HEART PATIENTSJennifer Ledbetter, RN, MSN,Vice President of Operations, Medical City Heart Hospital and Medical City Spine Hospital, HCA Healthcare COALA LIFEAMY DAVALLE, PRESIDENTVENUS MEDTECHERIC ZI,CO-FOUNDER AND CEO1916CORSANO HEALTHDRS. PETER C. STAS,CEO20TOP 10CARDIOVASCULARSOLUTIONS PROVIDERS - 2023CARDIONEW IMPELLA 5.5 HEART PUMP DEVICE PROVIDES POTENTIALLY LIFE-SAVING TREATMENT OPTION FOR PATIENTS WITH CARDIOGENIC SHOCKMark Anderson, M.D., Chief of the Division of Cardiac Surgery and Cardiothoracic Surgeon, Heart and Vascular Hospital, Hackensack University Medical Center and Hackensack Meridian Health30
< Page 4 | Page 6 >